Immuneering

Develops oncology medicines using a computational bioinformatics platform.

BiotechnologyPharmaceuticals immuneering.com ↗

Company facts

Founded
2008
Employees
60
Headquarters
United States
Type
Public
Listed
NASDAQ: IMRX